In TARGET, GSE16476, GSE85047 and E-MTAB-1781 datasets, the E2F1 expression levels were higher in neuroblastoma patients with age at diagnosis ≥ 18 months than neuroblastoma patients with age at diagnosis < 18 months (Fig. 4a). The gene discussed is E2F1; the disease is neuroblastoma.